| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.
|
J Clin Oncol
|
1994
|
2.14
|
|
2
|
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.
|
N Engl J Med
|
1988
|
1.67
|
|
3
|
A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy.
|
Bone Marrow Transplant
|
2006
|
1.66
|
|
4
|
Pressor effect of naloxone in septic shock.
|
Lancet
|
1981
|
1.53
|
|
5
|
Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer.
|
N Engl J Med
|
1993
|
1.45
|
|
6
|
Retinopathy and optic neuropathy in bone marrow transplantation for breast cancer.
|
Ophthalmology
|
1996
|
1.44
|
|
7
|
Randomized trial of high-dose chemotherapy with autologous bone marrow support as adjuvant therapy for high-risk, multi-node-positive malignant melanoma.
|
J Natl Cancer Inst
|
1993
|
1.40
|
|
8
|
Physician-assisted suicide and advance directives concerning life support.
|
N C Med J
|
1993
|
1.39
|
|
9
|
High-dose chemotherapy and autologous stem cell transplantation for breast cancer.
|
Cancer Invest
|
2000
|
1.37
|
|
10
|
Evidence for RNA tumor viruses in human lymphomas including Burkitt's disease.
|
Cancer Res
|
1973
|
1.19
|
|
11
|
Corticosteroid administration and localized leukocyte mobilization in man.
|
N Engl J Med
|
1972
|
1.05
|
|
12
|
Characterisation of a virus (HL23V) isolated from cultured acute myelogenous leukaemic cells.
|
Nature
|
1976
|
1.01
|
|
13
|
Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support.
|
J Clin Oncol
|
1999
|
0.96
|
|
14
|
Expression of interleukin-1 alpha, interleukin-1 beta, and an interleukin-1 receptor antagonist in human retinal pigment epithelial cells.
|
Exp Eye Res
|
1992
|
0.96
|
|
15
|
Pharmacokinetics and immediate effects of high-dose carmustine in man.
|
Cancer Treat Rep
|
1986
|
0.95
|
|
16
|
Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-alpha.
|
Am J Obstet Gynecol
|
1992
|
0.94
|
|
17
|
Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients.
|
J Infect Dis
|
1992
|
0.94
|
|
18
|
Clinical and pharmacological phase I evaluation of Exherin (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours.
|
Ann Oncol
|
2009
|
0.93
|
|
19
|
Biological and biochemical evidence for an interaction between Marek's disease herpesvirus and avian leukosis virus in vivo.
|
Proc Natl Acad Sci U S A
|
1973
|
0.91
|
|
20
|
Pulmonary drug toxicity in patients with primary breast cancer treated with high-dose combination chemotherapy and autologous bone marrow transplantation.
|
Am Rev Respir Dis
|
1993
|
0.89
|
|
21
|
Unique nuclear DNA sequences in the involved tissues of Hodgkin's and Burkitt's lymphomas.
|
Proc Natl Acad Sci U S A
|
1973
|
0.89
|
|
22
|
Elimination of malignant clonogenic breast cancer cells from human bone marrow.
|
Cancer Res
|
1989
|
0.88
|
|
23
|
Synergistic cytotoxicity of different alkylating agents for epithelial ovarian cancer.
|
Int J Cancer
|
1991
|
0.86
|
|
24
|
Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support.
|
Blood
|
1993
|
0.85
|
|
25
|
Thrombotic microangiopathy as a complication of high-dose chemotherapy for breast cancer.
|
Bone Marrow Transplant
|
1996
|
0.85
|
|
26
|
Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer.
|
Cancer Chemother Pharmacol
|
1998
|
0.84
|
|
27
|
Myocardial ischemia associated with high-dose carmustine infusion.
|
Cancer
|
1991
|
0.84
|
|
28
|
Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
|
Cancer Res
|
1987
|
0.83
|
|
29
|
Modulation of macrophage colony stimulating factor in cultured human retinal pigment epithelial cells.
|
Exp Eye Res
|
1992
|
0.82
|
|
30
|
Cost analysis of pancreatic carcinoma treatment.
|
Cancer
|
2000
|
0.82
|
|
31
|
A randomized trial of recombinant human interleukin-11 following autologous bone marrow transplantation with peripheral blood progenitor cell support in patients with breast cancer.
|
Biol Blood Marrow Transplant
|
1998
|
0.82
|
|
32
|
Measurement of busulfan in plasma by high-performance liquid chromatography.
|
J Chromatogr
|
1987
|
0.82
|
|
33
|
The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic support.
|
Biol Blood Marrow Transplant
|
1997
|
0.82
|
|
34
|
High-dose combination alkylating agents with autologous bone marrow support: a Phase 1 trial.
|
J Clin Oncol
|
1986
|
0.81
|
|
35
|
Alterations in L-selectin expression and elastase activity in neutrophils from patients receiving granulocyte colony-stimulating factor alone or in conjunction with high-dose chemotherapy with autologous bone marrow transplantation.
|
Lymphokine Cytokine Res
|
1994
|
0.81
|
|
36
|
High-dose combination alkylating agents with autologous bone-marrow support in patients with breast cancer: preliminary assessment of DNA damage in individual peripheral blood lymphocytes using the single cell gel electrophoresis assay.
|
Mutat Res
|
1992
|
0.81
|
|
37
|
Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
|
Cancer
|
1995
|
0.80
|
|
38
|
Changes in plasma transforming growth factor beta in response to high-dose chemotherapy for stage II breast cancer: possible implications for the prevention of hepatic veno-occlusive disease and pulmonary drug toxicity.
|
Bone Marrow Transplant
|
1995
|
0.80
|
|
39
|
Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support.
|
Blood
|
1994
|
0.80
|
|
40
|
Pharmacokinetics of dibromodulcitol in humans: a phase I study.
|
J Clin Oncol
|
1986
|
0.80
|
|
41
|
A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies.
|
Cancer Chemother Pharmacol
|
1996
|
0.80
|
|
42
|
Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant.
|
J Clin Oncol
|
1998
|
0.79
|
|
43
|
Protection against chemotherapy-induced alopecia by cyclosporin A in the newborn rat animal model.
|
Dermatology
|
1995
|
0.79
|
|
44
|
Altered immunologic reconstitution after standard-dose chemotherapy or high-dose chemotherapy with autologous bone marrow support.
|
Transplantation
|
1988
|
0.79
|
|
45
|
The analysis of relapse-free survival curves: implications for evaluating intensive systemic adjuvant treatment regimens for breast cancer.
|
Br J Cancer
|
2005
|
0.79
|
|
46
|
Prevention of hemorrhagic cystitis after high-dose alkylating agent chemotherapy and autologous bone marrow support.
|
Bone Marrow Transplant
|
1994
|
0.79
|
|
47
|
Pulmonary drug toxicity following high-dose chemotherapy with autologous bone marrow transplantation: CT findings in 20 cases.
|
J Thorac Imaging
|
1994
|
0.79
|
|
48
|
Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
|
Bone Marrow Transplant
|
2000
|
0.79
|
|
49
|
A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation.
|
Bone Marrow Transplant
|
1997
|
0.79
|
|
50
|
High-dose chemotherapy and hematopoietic stem cell transplantation for breast cancer: past or future?
|
Semin Oncol
|
2001
|
0.79
|
|
51
|
Relation of glutathione S-transferase alpha and mu isoforms to response to therapy in human breast cancer.
|
Clin Cancer Res
|
1997
|
0.79
|
|
52
|
Evaluation of symptom distress in a bone marrow transplant outpatient environment.
|
Ann Pharmacother
|
1996
|
0.78
|
|
53
|
Autologous bone marrow transplantation and factor XII, factor VII, and protein C deficiencies. Report of a new association and its possible relationship to endothelial cell injury.
|
Cancer
|
1990
|
0.78
|
|
54
|
Familial Burkitt's lymphoma. Association with altered lymphocyte subsets in family members.
|
Am J Med
|
1986
|
0.78
|
|
55
|
Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation.
|
Bone Marrow Transplant
|
1991
|
0.78
|
|
56
|
Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno-occlusive disease of the liver.
|
Bone Marrow Transplant
|
1998
|
0.78
|
|
57
|
Cost implications of haematopoietic growth factors in the BMT setting.
|
Bone Marrow Transplant
|
1993
|
0.78
|
|
58
|
Hematopoietic colony-stimulating factors and dose intensity.
|
Semin Oncol
|
1993
|
0.77
|
|
59
|
A comparison of immunohistochemistry, two-color immunofluorescence, and flow cytometry with cell sorting for the detection of micrometastatic breast cancer in the bone marrow.
|
J Hematother
|
1996
|
0.77
|
|
60
|
Measuring DNA damage in individual cells of heterogeneous mixtures: a novel application of an immunological typing technique.
|
Mutat Res
|
1994
|
0.77
|
|
61
|
Recombinant human granulocyte-macrophage colony-stimulating factor produces fever.
|
Lancet
|
1988
|
0.77
|
|
62
|
Breast cancer cells are effectively purged from peripheral blood progenitor cells with an immunomagnetic technique.
|
Clin Cancer Res
|
1996
|
0.77
|
|
63
|
The addition of paclitaxel to continuous infusion 5-fluorouracil is an active regimen for metastatic breast cancer.
|
Am J Clin Oncol
|
1998
|
0.77
|
|
64
|
Endogenous digoxin-like immunoreactive factor and digitalis-like factor associated with the hypertension of patients receiving multiple alkylating agents as part of autologous bone marrow transplantation.
|
Clin Sci (Lond)
|
1989
|
0.77
|
|
65
|
High-dose chemotherapy and CD34-selected peripheral blood progenitor cell transplantation for patients with breast cancer metastatic to bone and/or bone marrow.
|
Bone Marrow Transplant
|
2001
|
0.77
|
|
66
|
High-dose chemotherapy-induced platelet defect: inhibition of platelet signal transduction pathways.
|
Mol Pharmacol
|
1993
|
0.77
|
|
67
|
Advances in the clinical use of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor to intensify cancer chemotherapy.
|
Curr Opin Hematol
|
1994
|
0.76
|
|
68
|
Sequences related to the RNA tumor viruses in the RNA and DNA of human leukemias and lymphomas.
|
Bibl Haematol
|
1975
|
0.76
|
|
69
|
High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experience.
|
Cancer Treat Rep
|
1987
|
0.76
|
|
70
|
The significance of microbial cultures of the hematopoietic support for patients receiving high-dose chemotherapy.
|
J Hematother
|
1996
|
0.76
|
|
71
|
Malignant melanoma. Treatment with high-dose combination alkylating agent chemotherapy and autologous bone marrow support.
|
Arch Dermatol
|
1988
|
0.76
|
|
72
|
Successful allogeneic bone marrow transplantation in selected patients over 50 years of age--a single institution's experience.
|
Bone Marrow Transplant
|
1998
|
0.76
|
|
73
|
High-dose chemotherapy and autologous bone marrow support for breast cancer.
|
Important Adv Oncol
|
1991
|
0.75
|
|
74
|
The use of growth factors with antibiotics in the setting of neutropenic fever.
|
Am J Med
|
1996
|
0.75
|
|
75
|
Contributions from the American Medical Political Action Committee to members of Congress.
|
N Engl J Med
|
1994
|
0.75
|
|
76
|
Modifying hematopoiesis with colony-stimulating factors.
|
Am J Clin Pathol
|
1992
|
0.75
|
|
77
|
Prediction of the optimal timing of bone marrow reinfusion after high dose chemotherapy.
|
Cancer Res
|
1986
|
0.75
|
|
78
|
Distribution of 99Tcm-sulphur colloid during granulocyte colony-stimulating factor administration in autologous bone marrow transplantation.
|
Nucl Med Commun
|
1993
|
0.75
|
|
79
|
Hypertension and reversible myocardial depression associated with autologous bone marrow transplantation.
|
Am J Med
|
1990
|
0.75
|
|
80
|
Detection of tumor cells in the bone marrow of stage IV breast cancer patients receiving high-dose chemotherapy: the role of induction chemotherapy.
|
Bone Marrow Transplant
|
1995
|
0.75
|
|
81
|
Randomized, comparative study of high-dose (with autologous bone marrow support) versus low-dose cyclophosphamide, cisplatin, and carmustine as consolidation to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for patients with operable stage II or III breast cancer involving 10 or more axillary lymph nodes (CALGB Protocol 9082). Cancer and Leukemia Group B.
|
J Natl Cancer Inst Monogr
|
1995
|
0.75
|
|
82
|
Guillain-Barre syndrome following autologous bone marrow transplantation.
|
Am J Clin Oncol
|
1995
|
0.75
|
|
83
|
Effect of plasma TNF-alpha on filgrastim-stimulated hematopoiesis in mice and humans.
|
Pharmacotherapy
|
1998
|
0.75
|
|
84
|
High-dose carboplatin, cyclophosphamide, and BCNU with autologous bone marrow support: excessive hepatic toxicity.
|
Cancer Chemother Pharmacol
|
1990
|
0.75
|
|
85
|
Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres.
|
Cancer
|
1991
|
0.75
|
|
86
|
Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin.
|
Bone Marrow Transplant
|
1990
|
0.75
|
|
87
|
Phase-I trial of combination therapy with continuous-infusion MMPR and continuous-infusion 5-FU.
|
Cancer Chemother Pharmacol
|
1984
|
0.75
|
|
88
|
Ocular toxicity following high dose chemotherapy and autologous transplant.
|
Bone Marrow Transplant
|
1996
|
0.75
|
|
89
|
Retroviral gene transduction of circulating progenitor cells in patients with metastatic breast cancer.
|
Surg Oncol
|
1993
|
0.75
|
|
90
|
Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complement.
|
Cancer Res
|
1987
|
0.75
|
|
91
|
A radiologic syndrome after high dose chemotherapy and autologous bone marrow transplantation, with clinical and pathologic features of systemic candidiasis.
|
Cancer
|
1994
|
0.75
|
|
92
|
Detection of breast carcinoma cells in human bone marrow using fluorescence-activated cell sorting and conventional cytology.
|
Am J Clin Pathol
|
1990
|
0.75
|
|
93
|
RNA tumor viruses and human lymphomas.
|
Hamatol Bluttransfus
|
1974
|
0.75
|
|
94
|
The impact of conventional plus high dose chemotherapy with autologous bone marrow transplantation on hematologic toxicity during subsequent local-regional radiotherapy for breast cancer.
|
Cancer
|
1994
|
0.75
|
|
95
|
Phase I study of recombinant human interleukin-1 beta (rhIL-1 beta) in patients with bone marrow failure.
|
Bone Marrow Transplant
|
1994
|
0.75
|
|
96
|
Clinical pharmacology of filgrastim following high-dose chemotherapy and autologous bone marrow transplantation.
|
Clin Cancer Res
|
1997
|
0.75
|
|
97
|
Contrasting characteristics of Marek's disease herpesvirus isolated from chickens with and without avian leukosis virus infection.
|
Intervirology
|
1978
|
0.75
|
|
98
|
Changes in actin state and chemotactic peptide receptor expression in granulocytes during cytokine administration after autologous bone marrow transplantation.
|
Lymphokine Cytokine Res
|
1992
|
0.75
|
|
99
|
Elevated endogenous serum macrophage colony-stimulating factor in the early stage of fungemia following bone marrow transplantation.
|
Exp Hematol
|
1994
|
0.75
|
|
100
|
Impact of consolidation radiotherapy in patients with advanced breast cancer treated with high-dose chemotherapy and autologous bone marrow rescue.
|
J Clin Oncol
|
1999
|
0.75
|
|
101
|
The pharmacologic effects of recombinant, human colony-stimulating factors and their modulation by theophylline.
|
Pharmacotherapy
|
1997
|
0.75
|
|
102
|
Bone marrow and peripheral blood hematopoietic stem cell transplantation: focus on autografting.
|
Clin Chem
|
2000
|
0.75
|
|
103
|
Reticulated platelet counts in patients undergoing autologous bone marrow transplantation: an aid in assessing marrow recovery.
|
Am J Hematol
|
1994
|
0.75
|
|
104
|
Disposition of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving high-dose chemotherapy and autologous bone marrow support.
|
Blood
|
1992
|
0.75
|
|
105
|
Autologous bone marrow transplantation in breast cancer. A panel discussion.
|
Breast Cancer Res Treat
|
1988
|
0.75
|
|
106
|
Artifactual hypoglycemia associated with hematopoietic cytokines.
|
Arch Pathol Lab Med
|
1995
|
0.75
|